{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:31:07Z","timestamp":1786980667929,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s10384-022-00962-9","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T05:18:39Z","timestamp":1669180719000},"page":"14-21","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["A multicenter study of ocular inflammation after COVID-19 vaccination"],"prefix":"10.1007","volume":"67","author":[{"given":"Yuta","family":"Yasaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Keino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Usui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuichi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshikatsu","family":"Kaburaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiju","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sentaro","family":"Kusuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Takase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoji","family":"Yanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiharu","family":"Iwahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuki","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Ohguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh-Hei","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"JOIS Uveitis Survey Working Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"key":"962_CR1","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603\u201315.","journal-title":"N Engl J Med"},{"key":"962_CR2","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384:403\u201316.","journal-title":"N Engl J Med"},{"key":"962_CR3","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","volume":"384","author":"J Sadoff","year":"2021","unstructured":"Sadoff J, Gray G, Vandebosch A, C\u00e1rdenas V, Shukarev G, Grinsztejn B, et al. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. N Engl J Med. 2021;384:2187\u2013201.","journal-title":"N Engl J Med"},{"key":"962_CR4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","volume":"397","author":"M Voysey","year":"2021","unstructured":"Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397:99\u2013111.","journal-title":"Lancet"},{"key":"962_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1126\/science.abc1932","volume":"369","author":"Q Gao","year":"2020","unstructured":"Gao Q, Bao L, Mao H, Wang L, Xu K, Yang M, et al. Development of an inactivated vaccine candidate for SARS-CoV-2. Science. 2020;369:77\u201381.","journal-title":"Science"},{"key":"962_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S1473-3099(20)30831-8","volume":"21","author":"S Xia","year":"2021","unstructured":"Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, et al. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1\/2 trial. Lancet Infect Dis. 2021;21:39\u201351.","journal-title":"Lancet Infect Dis"},{"key":"962_CR7","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1056\/NEJMoa2107659","volume":"385","author":"PT Heath","year":"2021","unstructured":"Heath PT, Galiza EP, Baxter DN, Boffito M, Browne D, Burns F, et al. Safety and efficacy of NVX-CoV2373 Covid-19 vaccine. N Engl J Med. 2021;385:1172\u201383.","journal-title":"N Engl J Med"},{"key":"962_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s40123-021-00415-5","volume":"11","author":"XL Ng","year":"2022","unstructured":"Ng XL, Betzler BK, Ng S, Chee SP, Rajamani L, Singhal A, et al. The eye of the storm: COVID-19 vaccination and the eye. Ophthalmol Ther. 2022;11:81\u2013100.","journal-title":"Ophthalmol Ther"},{"key":"962_CR9","first-page":"48","volume":"113","author":"M Benage","year":"2016","unstructured":"Benage M, Fraunfelder FW. Vaccine-associated uveitis. Mo Med. 2016;113:48\u201352.","journal-title":"Mo Med"},{"key":"962_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ajo.2022.02.011","volume":"240","author":"MTM Wang","year":"2022","unstructured":"Wang MTM, Niederer RL, McGhee CNJ, Danesh-Meyer HV. COVID-19 vaccination and the eye. Am J Ophthalmol. 2022;240:79\u201398.","journal-title":"Am J Ophthalmol"},{"key":"962_CR11","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1080\/09273948.2021.1976221","volume":"29","author":"XL Ng","year":"2021","unstructured":"Ng XL, Betzler BK, Testi I, Ho SL, Tien M, Ngo WK, et al. Ocular adverse events after COVID-19 vaccination. Ocul Immunol Inflamm. 2021;29:1216\u201324.","journal-title":"Ocul Immunol Inflamm"},{"key":"962_CR12","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3390\/vaccines10020342","volume":"10","author":"AA Haseeb","year":"2022","unstructured":"Haseeb AA, Solyman O, Abushanab MM, Abo Obaia AS, Elhusseiny AM. Ocular complications following vaccination for COVID-19: a one-year retrospective. Vaccines (Basel). 2022;10:342.","journal-title":"Vaccines (Basel)"},{"key":"962_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12348-021-00275-x","volume":"12","author":"I Testi","year":"2022","unstructured":"Testi I, Brand\u00e3o-de-Resende C, Agrawal R, Pavesio C. Ocular inflammatory events following COVID-19 vaccination: a multinational case series. J Ophthalmic Inflamm Infect. 2022;12:4.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"962_CR14","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.3390\/jcm10245960","volume":"10","author":"E Bolletta","year":"2021","unstructured":"Bolletta E, Iannetta D, Mastrofilippo V, De Simone L, Gozzi F, Croci S, et al. Uveitis and other ocular complications following COVID-19 vaccination. J Clin Med. 2021;10:5960.","journal-title":"J Clin Med"},{"key":"962_CR15","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0002-9394(01)00925-4","volume":"131","author":"RW Read","year":"2001","unstructured":"Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131:647\u201352.","journal-title":"Am J Ophthalmol"},{"key":"962_CR16","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3390\/vaccines10030482","volume":"10","author":"X Chen","year":"2022","unstructured":"Chen X, Li X, Li H, Li M, Gong S. Ocular adverse events after inactivated COVID-19 vaccination in Xiamen. Vaccines (Basel). 2022;10:482.","journal-title":"Vaccines (Basel)"},{"key":"962_CR17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s10384-020-00809-1","volume":"65","author":"KH Sonoda","year":"2021","unstructured":"Sonoda KH, Hasegawa E, Namba K, Okada AA, Ohguro N, Goto H, et al. Epidemiology of uveitis in Japan: a 2016 retrospective nationwide survey. Jpn J Ophthalmol. 2021;65:184\u201390.","journal-title":"Jpn J Ophthalmol"},{"key":"962_CR18","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3390\/vaccines9050435","volume":"9","author":"A Watad","year":"2021","unstructured":"Watad A, De Marco G, Mahajna H, Druyan A, Eltity M, Hijazi N, et al. Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination. Vaccines (Basel). 2021;9:435.","journal-title":"Vaccines (Basel)"},{"key":"962_CR19","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/IAE.0000000000002816","volume":"40","author":"ET Cunningham","year":"2020","unstructured":"Cunningham ET, Moorthy RS. Vaccine-associated posterior uveitis. Retina. 2020;40:595\u20138.","journal-title":"Retina"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-022-00962-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-022-00962-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-022-00962-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T07:12:37Z","timestamp":1674630757000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10384-022-00962-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["962"],"URL":"https:\/\/doi.org\/10.1007\/s10384-022-00962-9","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,22]]},"assertion":[{"value":"13 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y. Yasaka, None; E. Hasegawa, None; H. Keino, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Novartis, Nikon, Kowa, ZEISS, Mitsubishi Tanabe, Santen, Bayer, Senju, AbbVie); Y. Usui, None; K. Maruyama, None; Y. Yamamoto, None; T. Kaburaki, Grants or contracts (AbbVie, Santen, Alcon, Senju, HOYA, Novartis), Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Santen, Novartis, Eisai, AbbVie, Mitsubishi Tanabe, Kowa, Wakamoto, Senju, Ono); D. Iwata, None; M. Takeuchi, None; S. Kusuhara, None; H. Takase, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Santen, Novartis, AbbVie, Senju, Eisai, Otsuka), Patents planned, issued or pending (Japanese Patent Application No. 2019-107483); K. Nagata, Grants or contracts (AMO), Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Novartis, Senju, Kowa, AbbVie, Santen); R. Yanai, None; Y. Kaneko, None; C. Iwahashi, None; A. Fukushima, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Santen, Senju, Johnson & Johnson, Novartis, Rohto Nitten, Mitsubishi Tanabe); N. Ohguro, None; K. Sonoda, None.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}